D. Chew

Deepak L. Bhatt, S. Kapadia, M. Roffi, 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Relation of Body Mass Index to Outcomes in Acute Coronary Syndrome.

D. Chew, D. Brieger, M. D'Souza, 2020, The American journal of cardiology.

Implementation of more sensitive cardiac troponin T assay in a state-wide health service.

D. Chew, T. Briffa, Benjamin C. Sun, 2021, International journal of cardiology.

Clinical end point definitions after percutaneous coronary intervention and their relationship to late mortality: an assessment by attributable risk

Deepak L. Bhatt, E. Topol, A. Lincoff, 2005, Heart.

Oral glycoprotein IIb/IIIa antagonists in coronary artery disease

Deepak L. Bhatt, D. Chew, 2001, Current cardiology reports.

Catheter-Based Renal Denervation for Resistant Hypertension: 12-Month Results of the EnligHTN I First-in-Human Study Using a Multielectrode Ablation System

C. Tsioufis, I. Meredith, V. Papademetriou, 2014, Hypertension.

Should fee-for-service be for all guideline-advocated acute coronary syndrome (ACS) care? Observations from the Snapshot ACS study.

D. Chew, D. Brieger, T. Briffa, 2015, Australian health review : a publication of the Australian Hospital Association.

Ischemic and bleeding outcomes in women treated with bivalirudin during percutaneous coronary intervention: a subgroup analysis of the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial.

E. Topol, A. Lincoff, A. Lansky, 2006, American heart journal.

Plasma Surfactant Protein-B: A Novel Biomarker in Chronic Heart Failure

P. Aylward, D. Chew, A. Bersten, 2004, Circulation.

Trends in incidence and prevalence of hospitalization for atrial fibrillation and associated mortality in Western Australia, 1995-2010.

G. Hankey, J. Eikelboom, J. Hung, 2016, International journal of cardiology.

Phase 4 Studies in Heart Failure - What is Done and What is Needed?

Merlin C. Thomas, Merlin C Thomas, D. Liew, 2016, Current cardiology reviews.

Effect of abciximab versus tirofiban on activated clotting time during percutaneous intervention and its relation to clinical outcomes--observations from the TARGET trial.

E. Topol, G. Stone, B. Meier, 2003, The American journal of cardiology.

Objective risk assessment vs standard care for acute coronary syndromes—The Australian GRACE Risk tool Implementation Study (AGRIS): a process evaluation

A. Yan, S. Goodman, C. Gale, 2022, BMC Health Services Research.

Outpatient heart failure programs: time for a new standard

D. Chew, A. Halabi, 2018, The Medical journal of Australia.

Reperfusion After Fibrinolytic Therapy (RAFT): An open-label, multi-centre, randomised controlled trial of bivalirudin versus heparin in rescue percutaneous coronary intervention

D. Chew, D. Walters, J. French, 2021, PloS one.

Antiplatelet therapy in percutaneous coronary intervention: recent advances in oral antiplatelet agents

D. Chew, R. Prakash, Y. Wong, 2010, Current opinion in cardiology.

Six-month survival benefits associated with clinical guideline recommendations in acute coronary syndromes

K. Eagle, J. Gore, D. Chew, 2010, Heart.

Intravenous platelet blockade with cangrelor during PCI.

Deepak L. Bhatt, H. White, G. Stone, 2009, The New England journal of medicine.

Potential survival gains in the treatment of myocardial infarction

D. Liew, D. Chew, D. Brieger, 2009, Heart.

2007 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand Guidelines for the management of acute coronary syndromes 2006

H. White, P. Aylward, D. Chew, 2008, The Medical journal of Australia.

Oral Glycoprotein IIb/IIIa Inhibitors

Deepak L. Bhatt, E. Topol, D. Chew, 2001 .

Comparative Overview of ST-Elevation Myocardial Infarction (STEMI) Epidemiology, Demographics, Management and Outcomes in 5 Asia-Pacific Countries - A Meta-Analysis.

C. Reid, Y. Ahn, I. Komuro, 2020, European heart journal. Quality of care & clinical outcomes.

Characteristics and Clinical Course of STEMI Patients who Received no Reperfusion in the Australia and New Zealand SNAPSHOT ACS Registry.

D. Chew, D. Brieger, J. Rankin, 2016, Heart, lung & circulation.

Comparison of the management and in‐hospital outcomes of acute coronary syndrome patients in Australia and New Zealand: results from the binational SNAPSHOT acute coronary syndrome 2012 audit

I. Ranasinghe, H. White, G. Gamble, 2015, Internal medicine journal.

Evaluation and management of patients with acute chest pain in China (EMPACT): protocol for a prospective, multicentre registry study

Hao Wang, D. Chew, Feng Xu, 2018, BMJ Open.

P2Y12 Inhibitor Pre-Treatment in Non-ST-Elevation Acute Coronary Syndrome: A Decision-Analytic Model

D. Chew, J. Langrish, A. Chuang, 2016, Journal of clinical medicine.

The relationship between the proportion of admitted high risk ACS patients and hospital delivery of evidence based care.

A. Yan, S. Goodman, J. Amerena, 2016, International journal of cardiology.

Clinical characteristics and outcomes after unplanned intraaortic balloon counterpulsation in the Counterpulsation to Reduce Infarct Size Pre-PCI Acute Myocardial Infarction trial.

E. Ohman, H. Thiele, Manesh R Patel, 2016, American heart journal.

The clinical care standards in ACS: towards an integrated approach to evidence translation in ACS care.

D. Chew, T. Briffa, 2015, Heart, lung & circulation.

Current management of acute coronary syndromes in Australia: observations from the acute coronary syndromes prospective audit

J. Amerena, D. Chew, D. Brieger, 2007, Internal medicine journal.

Variations in the application of cardiac care in Australia

D. Chew, D. Brieger, D. Walters, 2008, The Medical journal of Australia.

Late Outcomes of the RAPID-TnT Randomized Controlled Trial

J. Karnon, D. Chew, A. Nelson, 2021, Circulation.

Asian Pacific Society of Cardiology Consensus Recommendations on Dyslipidaemia

K. Kostner, H. Tse, T. Subramaniam, 2021, European cardiology.

2020 Asian Pacific Society of Cardiology Consensus Recommendations on the Use of P2Y12 Receptor Antagonists in the Asia-Pacific Region

W. Almahmeed, G. Montalescot, D. Chew, 2021, European cardiology.

Acute coronary syndromes: consensus recommendations for translating knowledge into action

D. Chew, D. Brieger, A. Kelly, 2010, The Medical journal of Australia.

Influence of metabolic syndrome on outcome after percutaneous coronary intervention

Deepak L. Bhatt, S. Ellis, Vijay Nambi, 2011 .

Initial experience with the balloon expandable Edwards-SAPIEN Transcatheter Heart Valve in Australia and New Zealand: the SOURCE ANZ registry: outcomes at 30 days and one year.

P. Jansz, D. Chew, D. Walters, 2014, International journal of cardiology.

Availability of highly sensitive troponin assays and acute coronary syndrome care: insights from the SNAPSHOT registry

D. Chew, D. Brieger, T. Briffa, 2015, The Medical journal of Australia.

Abstract 19523: Catheter-Based Renal Denervation for the Treatment of Patients with Drug-Resistant Hypertension: EnligHTN I: Three-Month Data of a First in Man Study Using a Multi-Electrode Radiofrequency Ablation Catheter

C. Tsioufis, I. Meredith, V. Papademetriou, 2012 .

Clinical Characteristics, Management, and Outcomes of Acute Coronary Syndrome in Patients With Right Bundle Branch Block on Presentation.

W. K. Chan, J. López-Sendón, A. Yan, 2016, The American journal of cardiology.

Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction.

Deepak L. Bhatt, E. Topol, S. Ellis, 2002, The American journal of cardiology.

Death Following Creatine Kinase-MB Elevation After Coronary Intervention: Identification of an Early Risk Period: Importance of Creatine Kinase-MB Level, Completeness of Revascularization, Ventricular Function, and Probable Benefit of Statin Therapy

E. Topol, S. Ellis, D. Chew, 2002, Circulation.

Early and Sustained Survival Benefit Associated With Statin Therapy at the Time of Percutaneous Coronary Intervention

Deepak L. Bhatt, E. Topol, S. Ellis, 2002, Circulation.

Applying evidence-based medicine in the coronary care unit

D. Chew, L. Huynh, 2011 .

Acute coronary syndromes: consensus recommendations for translating knowledge into action

P. Aylward, D. Chew, D. Brieger, 2010 .

Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.

J. Ware, S. Steinhubl, E. Ohman, 2008, JACC. Cardiovascular interventions.

Morbidity, mortality and economic burden of renal impairment in cardiac intensive care

D. Chew, D. Chew, C. Astley, 2006, Internal medicine journal.

Bivalirudin provides increasing benefit with decreasing renal function: a meta-analysis of randomized trials.

Deepak L. Bhatt, T. Henry, A. Lincoff, 2003, The American journal of cardiology.

Predictors of Statin‐Induced Regression of Left Anterior Descending Coronary Artery Wall Thickness as Measured by High‐Resolution Transthoracic Echocardiography

P. Aylward, D. Chew, R. Perry, 2012, Echocardiography.

Early and Sustained Survival Benefit Associated With Statin Therapy at the Time of Percutaneous Coronary Intervention

Deepak L. Bhatt, E. Topol, S. Ellis, 2002 .

Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (a subanalysis of the REPLACE-2 trial).

E. Topol, T. Henry, A. Lincoff, 2005, The American journal of cardiology.

A randomised study of three different informational AIDS prior to coronary angiography, measuring patient recall, satisfaction and anxiety.

P. Aylward, D. Chew, C. D. De Pasquale, 2008, Heart, lung & circulation.

English as a second language and outcomes of patients presenting with acute coronary syndromes: results from the CONCORDANCE registry

D. Chew, D. Brieger, L. Kritharides, 2016, The Medical journal of Australia.

The household economic burden for acute coronary syndrome survivors in Australia

M. Woodward, I. Ranasinghe, S. Jan, 2016, BMC Health Services Research.

Acute coronary syndromes: consensus recommendations for translating knowledge into action

D. Chew, D. Brieger, A. Kelly, 2009, The Medical journal of Australia.

QRS duration alone misses cardiac dyssynchrony in a substantial proportion of patients with chronic heart failure.

P. Aylward, D. Chew, R. Perry, 2006, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

Evaluation of the impact of the GRACE risk score on the management and outcome of patients hospitalised with non-ST elevation acute coronary syndrome in the UK: protocol of the UKGRIS cluster-randomised registry-based trial

L. Sharples, D. Stocken, H. Hemingway, 2019, BMJ Open.

Biomarker-based risk model to predict cardiovascular events in patients with acute coronary syndromes – Results from BIPass registry

D. Chew, Feng Xu, Yuguo Chen, 2022, The Lancet regional health. Western Pacific.

Pharmacotherapy in Stable Coronary Artery Disease: Historical Perspectives and New Insights from the ISCHEMIA Trial

G. Stone, D. Chew, J. Tan, 2021, European cardiology.

Survival after an acute coronary syndrome: 18‐month outcomes from the Australian and New Zealand SNAPSHOT ACS study

G. Gamble, D. Chew, D. Brieger, 2015, The Medical journal of Australia.

Has invasive management for acute coronary syndromes become more ‘risk-appropriate’: pooled results of five Australian registries

J. Amerena, D. Chew, D. Brieger, 2017, European heart journal. Quality of care & clinical outcomes.

Effect of revascularization on mortality associated with an elevated white blood cell count in acute coronary syndromes.

Deepak L. Bhatt, E. Topol, S. Ommen, 2003, The American journal of cardiology.

Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy.

Deepak L. Bhatt, E. Topol, H. White, 2002, European heart journal.

Intravenous glycoprotein IIb/IIIa inhibition in non-ST segment elevation acute coronary syndromes.

E. Topol, M. Roffi, D. Chew, 2001, Progress in cardiovascular diseases.

Invasive management and late clinical outcomes in contemporary Australian management of acute coronary syndromes: observations from the ACACIA registry

J. Amerena, D. Chew, D. Brieger, 2008 .

An examination of clinical intuition in risk assessment among acute coronary syndromes patients: observations from a prospective multi-center international observational registry.

D. Chew, D. Brieger, S. Quinn, 2014, International journal of cardiology.

Invasive management and late clinical outcomes in contemporary Australian management of acute coronary syndromes: observations from the ACACIA registry

J. Amerena, D. Chew, D. Brieger, 2009, The Medical journal of Australia.

The predictive value of high sensitivity-troponin velocity within the first 6h of presentation for cardiac outcomes regardless of acute coronary syndrome diagnosis.

D. Chew, J. French, L. Cullen, 2016, International journal of cardiology.

Randomized Comparison of High-Sensitivity Troponin Reporting in Undifferentiated Chest Pain Assessment

M. Arstall, J. Beltrame, D. Chew, 2016, Circulation. Cardiovascular quality and outcomes.

The promise of high‐sensitivity troponin testing

D. Chew, L. Cullen, 2014, The Medical journal of Australia.

Optimizing glycoprotein IIb/IIIa inhibition: lessons from recent randomized controlled trials

Deepak L. Bhatt, D. Chew, 2002, Internal medicine journal.

Bivalirudin: an anticoagulant for acute coronary syndromes and coronary interventions

H. White, D. Chew, 2002, Expert opinion on pharmacotherapy.

GP IIb/IIIa inhibitors in coronary artery disease management: what the latest trials tell us.

D. Moliterno, D. Chew, 2001, Cleveland Clinic journal of medicine.

In unstable angina or non-ST-segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culprit-only stenting?

Deepak L. Bhatt, E. Topol, M. Lauer, 2007, Journal of the American College of Cardiology.

Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibi

R. Califf, H. White, K. Mahaffey, 2006, American heart journal.

Clinician assessment of acute coronary syndrome in the emergency department

R. Clark, D. Chew, C. Astley, 2018, British Journal of Cardiac Nursing.

Rewarming Temperature During Cardiopulmonary Bypass and Acute Kidney Injury: A Multicenter Analysis.

D. Chew, R. Baker, A. Mazzone, 2016, The Annals of thoracic surgery.

Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting.

N. Smedira, R. Hetzer, A. DeAnda, 2004, The American journal of cardiology.

Coronary artery bypass surgery in patients with acute coronary syndromes is difficult to predict.

R. Califf, H. White, K. Mahaffey, 2008, American heart journal.

Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.

S. Pocock, H. White, G. Stone, 2008, Journal of the American College of Cardiology.

Patients with non-ST-elevation acute coronary syndromes undergoing coronary artery bypass grafting in the modern era of antithrombotic therapy.

R. Califf, H. White, K. Mahaffey, 2008, American heart journal.

Raising the bar on guideline utility and trustworthiness

I. Scott, D. Chew, Maree G Branagan, 2017, Internal medicine journal (Print).

Surgical and percutaneous management of aboriginal Australians with rheumatic heart disease: Timeliness and concordance between practice and guidelines.

D. Chew, S. Nicholls, A. Brown, 2021, International journal of cardiology.

Defining the Optimal Activated Clotting Time During Percutaneous Coronary Intervention: Aggregate Results From 6 Randomized, Controlled Trials

Deepak L. Bhatt, E. Topol, A. Lincoff, 2001, Circulation.

Differences in treatment and management of indigenous and non-indigenous patients presenting with chest pain: results of the Heart Protection Partnership (HPP) study.

I. Ranasinghe, D. Chew, D. Brieger, 2009, Heart, lung & circulation.

Anticoagulation in Percutaneous Coronary Intervention

D. Chew, 2012 .

Impact of Non-Infarct-Related Artery Disease on Infarct Size and Outcomes (from the CRISP-AMI Trial).

Manesh R. Patel, E. Ohman, H. Thiele, 2016, The American journal of medicine.

Emergency revascularization was not associated with lower 30-day mortality in patients with acute MI complicated by cardiogenic shock

S. Ellis, D. Chew, 1999 .

Screening for important unwarranted variation in clinical practice: a triple-test of processes of care, costs and patient outcomes.

J. Karnon, D. Chew, D. Ben-Tovim, 2017, Australian health review : a publication of the Australian Hospital Association.

Text Messages to Improve Medication Adherence and Secondary Prevention After Acute Coronary Syndrome: The TEXTMEDS Randomized Clinical Trial

A. Rodgers, J. Atherton, A. Maiorana, 2022, Circulation.

Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial Infarction.

Sunil V. Rao, T. Henry, M. Krucoff, 2016, Journal of the American College of Cardiology.

Reduced immediate ischemic events with cangrelor in PCI: a pooled analysis of the CHAMPION trials using the universal definition of myocardial infarction.

Deepak L. Bhatt, H. White, G. Stone, 2012, American heart journal.

Generation of cardio-protective antibodies after pneumococcal polysaccharide vaccine: Early results from a randomised controlled trial.

A. Thrift, W. Abhayaratna, J. Attia, 2022, Atherosclerosis.

Statin doses after acute coronary syndrome

S. Dimmitt, Jennifer H. Martin, D. Chew, 2022, Australian prescriber.

Prevalence and Outcomes of Undiagnosed Peripheral Arterial Disease Among High Risk Patients in Australia: An Australian REACH Sub-Study.

Deepak L. Bhatt, C. Reid, Z. Ademi, 2019, Heart, lung & circulation.

High-resolution transthoracic echocardiography of the left anterior descending coronary artery: a novel noninvasive assessment of coronary vasoreactivity.

A. Mangoni, P. Aylward, D. Chew, 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

Mortality benefit of beta-blockade after successful elective percutaneous coronary intervention.

Deepak L. Bhatt, E. Topol, S. Ellis, 2002, Journal of the American College of Cardiology.

Bivalirudin in percutaneous coronary intervention

D. Chew, S. Lehman, 2006, Vascular health and risk management.

Bivalirudin, a bivalent, thrombin specific anticoagulant as an alternative to heparin in interventional procedures

D. Chew, 2002, Hämostaseologie.

Effect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous coronary intervention.

Deepak L. Bhatt, E. Topol, S. Ellis, 2004, The American journal of cardiology.

Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein.

Deepak L. Bhatt, E. Topol, S. Ellis, 2001, The American journal of cardiology.

Frailty and Outcomes After Myocardial Infarction: Insights From the CONCORDANCE Registry

K. Alexander, A. Bagai, A. Yan, 2018, Journal of the American Heart Association.

Randomized trials of clinical networks in the management of ST-elevation MI: can they be performed?

D. Chew, L. Blows, 2009, Current opinion in cardiology.

Facilitated percutaneous coronary intervention: Is this strategy ready for implementation?

H. White, P. Aylward, D. Chew, 2005, Current cardiology reports.

Catheter-based reperfusion in acute myocardial infarction

D. Chew, R. Brogan, M. Chuang, 2001, Interventional Cardiology and Cardiac Catheterisation.

Long-term antiplatelet therapy: from clinical trials to clinical application

D. Chew, Leong Lee, 2012, Current opinion in cardiology.

Direct thrombin inhibitors for percutaneous coronary intervention in the current era of platelet glycoprotein IIb/IIIa inhibition.

D. Chew, J. Reginelli, 2002, Journal of interventional cardiology.

Outcomes of cardiac surgery in Indigenous Australians

P. Aylward, D. Chew, S. Lehman, 2009, The Medical journal of Australia.

Balancing the Risks of Recurrent Ischaemic and Bleeding Events in a Stable Post ACS Population.

S. Goodman, J. Atherton, D. Chew, 2022, Heart, lung & circulation.

2011 Addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand Guidelines for the management of acute coronary syndromes (ACS) 2006.

H. White, P. Aylward, D. Chew, 2011, Heart, lung & circulation.

Cost‐effectiveness of drug‐eluting stents: if only all things were equal

D. Chew, Derek P. Chew, 2005, The Medical journal of Australia.

Differences in management and outcomes for men and women with ST‐elevation myocardial infarction

J. Atherton, J. Amerena, D. Chew, 2018, The Medical journal of Australia.

Impact of patient’s health-related quality of life on physicians’ therapy and perceived benefit in acute coronary syndromes: protocol for a systemic review of quantitative and qualitative studies

H. Gesesew, B. Kaambwa, D. Chew, 2019, BMJ Open.

Relation of platelet inactivation with intravenous glycoprotein IIb/IIIa antagonists to major bleeding (from the GOLD study).

Deepak L. Bhatt, S. Steinhubl, E. Topol, 2002, The American journal of cardiology.

Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention.

Deepak L. Bhatt, E. Topol, S. Ellis, 2004, The American journal of cardiology.

Australians at risk: management of cardiovascular risk factors in the REACH Registry.

C. Reid, M. Nelson, D. Chew, 2008, Heart, lung & circulation.

Use and outcomes of dual antiplatelet therapy for acute coronary syndrome in patients with chronic kidney disease: insights from the Canadian Observational Antiplatelet Study (COAPT)

A. Bagai, S. Mehta, A. Yan, 2022, Heart and Vessels.

Statin Therapy Alone and in Combination with an Acyl-CoA:Cholesterol O-Acyltransferase Inhibitor on Experimental Atherosclerosis

V. Fuster, Z. Fayad, J. Badimón, 2008, Pathophysiology of Haemostasis and Thrombosis.

Safety of abciximab during percutaneous coronary intervention in patients with chronic renal insufficiency.

Deepak L. Bhatt, E. Topol, A. Jeremias, 2002, The American journal of cardiology.

Intracoronary ECG during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction predicts microvascular obstruction and infarct size.

I. Meredith, D. Chew, M. Worthley, 2013, International Journal of Cardiology.

Acute pleiotropic effects of dapagliflozin in type 2 diabetic patients with heart failure with reduced ejection fraction: a crossover trial

A. Mangoni, D. Chew, J. Selvanayagam, 2021, ESC heart failure.

Pooled Analysis of Five Randomized Clinical Trials Adjunctive Treatment for Percutaneous Interventions of Aortocoronary Bypass Grafts : A Lack of Benefit From Intravenous Platelet Glycoprotein IIb / IIIa Receptor Inhibition as

Deepak L. Bhatt, E. Topol, S. Ellis, 2002 .

Clinical Application of Procedural Platelet Monitoring during Percutaneous Coronary Intervention among Patients at Increased Bleeding Risk

D. Moliterno, D. Chew, D. Mukherjee, 2001, Journal of Thrombosis and Thrombolysis.

Prognostic impact of types of atrial fibrillation in acute coronary syndromes.

P. Sanders, D. Chew, D. Lau, 2009, The American journal of cardiology.

Outcomes of anemic patients presenting with acute coronary syndrome: An analysis of the Cooperative National Registry of Acute Coronary Care, Guideline Adherence and Clinical Events

J. Hung, J. Mariani, D. Chew, 2019, Clinical cardiology.

A Comparison of Radial and Femoral Coronary Angiography in Patients From SNAPSHOT ACS, a Prospective Acute Coronary Syndrome Audit in Australia and New Zealand.

G. Gamble, D. Chew, D. Brieger, 2017, Heart, lung & circulation.

Evidence-based care in a population with chronic kidney disease and acute coronary syndrome. Findings from the Australian Cooperative National Registry of Acute Coronary Care, Guideline Adherence and Clinical Events (CONCORDANCE).

A. Cass, J. Hung, D. Chew, 2015, American heart journal.

An Assessment of Different Filter Systems for Extracorporeal Elimination of Bivalirudin: An In Vitro Study

H. Hausmann, A. Koster, B. Spiess, 2003, Anesthesia and analgesia.

Simple or Complex Stenting for Bifurcation Coronary Lesions: A Patient-Level Pooled-Analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study

Matti Niemelä, M. Niemelä, R. Stables, 2011, Circulation. Cardiovascular interventions.

Troponin measurements, myocardial infarction diagnoses and outcomes. An analysis of linked data from New South Wales, Australia

D. Chew, D. Brieger, T. Briffa, 2020, Internal medicine journal.

Suspected ACS Patients Presenting With Myocardial Damage or a Type 2 Myocardial Infarction Have a Similar Late Mortality to Patients With a Type 1 Myocardial Infarction: A Report From the Australian and New Zealand 2012 SNAPSHOT ACS Study.

D. Chew, D. Brieger, T. Briffa, 2017, Heart, lung & circulation.

"Bushfire Season" in Australia: Determinants of increases in risk of acute coronary syndromes and Takotsubo Syndrome.

J. Horowitz, D. Chew, M. Worthley, 2022, The American journal of medicine.

Balloon aortic valvuloplasty to bridge and triage patients in the era of trans‐catheter aortic valve implantation

D. Chew, A. Sinhal, C. Malkin, 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Effect of Balloon Aortic Valvuloplasty on Mortality in Patients With Severe Aortic Stenosis Prior to Conservative Treatment and Surgical or Transcatheter Aortic Valve Replacement.

D. Chew, J. Selvanayagam, S. Lehman, 2020, Heart, lung & circulation.

Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary intervention in Acu

J. Eikelboom, L. Ferguson, D. Chew, 2009, American heart journal.

Optimal Activated Clotting Time During Percutaneous Coronary Intervention

Deepak L. Bhatt, E. Topol, A. Lincoff, 2001 .

The Asia-Pacific Society of Cardiology (APSC) Expert Committee Consensus Recommendations for Assessment of Suspected Acute Coronary Syndrome Using High-Sensitivity Cardiac Troponin T in the Emergency Department.

Kenji Inoue, T. Aw, E. Giannitsis, 2019, Circulation journal : official journal of the Japanese Circulation Society.

Comparison of P2Y12 Inhibitors in Acute Coronary Syndromes in the Australian Population.

D. Chew, D. Brieger, L. Kritharides, 2022, Heart, lung & circulation.

New balance to an old complex problem

D. Chew, S. Lo, J. Tan, 2022, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients With Non–ST-Segment-Elevation Acute Coronary Syndromes Clinical Investigation and Reports

Deepak L. Bhatt, R. Califf, E. Topol, 2001 .

Condition-specific Streaming versus an Acuity-based Model of Cardiovascular Care: A Historically-controlled Quality Improvement Study Evaluating the Association with Early Clinical Events.

D. Chew, A. McGavigan, C. D. De Pasquale, 2016, Heart, lung & circulation.

Dual antiplatelet therapy with clopidogrel and aspirin after carotid artery stenting.

Deepak L. Bhatt, E. Topol, S. Kapadia, 2001, The Journal of invasive cardiology.

Polygenic risk score and coronary artery disease: A meta-analysis of 979,286 participant data.

P. Harst, G. Figtree, M. A. Said, 2021, Atherosclerosis.

Clinical care standards: appropriate care everywhere — acute coronary syndromes as an example

D. Chew, Meredith A Page, R. Herkes, 2016, The Medical journal of Australia.

The design and rationale of the Australian Cooperative National Registry of Acute Coronary care, Guideline Adherence and Clinical Events (CONCORDANCE).

I. Ranasinghe, A. Cass, F. Turnbull, 2013, Heart, lung & circulation.

Impact of the “Warning Signs Campaign” on Characteristics of Patients Presenting with Acute Coronary Syndrome (ACS) to Hospitals

D. Chew, D. Brieger, L. Kritharides, 2022, International journal of environmental research and public health.

The influence of travelling to hospital by ambulance on reperfusion time and outcomes for patients with STEMI

D. Chew, D. Brieger, L. Kritharides, 2021, The Medical journal of Australia.

Variation in coronary angiography rates in Australia: correlations with socio‐demographic, health service and disease burden indices

H. Buchan, D. Braddock, D. Chew, 2016, The Medical journal of Australia.

Rationale and design of a randomized controlled trial of pneumococcal polysaccharide vaccine for prevention of cardiovascular events: The Australian Study for the Prevention through Immunization of Cardiovascular Events (AUSPICE).

A. Thrift, A. Tonkin, W. Abhayaratna, 2016, American heart journal.

Abnormal Troponin Not Meeting Universal Definition of MI is Still High Risk

B. Pathik, D. Chew, A. Sinhal, 2013 .

Type 2 Myocardial Infarction is Associated with Worse Prognosis

D. Chew, A. Sinhal, M. Horsfall, 2013 .

Accuracy of Highly Limited Echocardiographic Screening Images for Determining a Structurally Normal Heart: The Quick-Six Study.

D. Chew, C. D. De Pasquale, A. Swan, 2021, Heart, lung & circulation.

The RADI PressureWire high-sensitivity thermistor and culprit lesion temperature in patients with acute coronary syndromes.

I. Meredith, D. Chew, M. Worthley, 2006, The Journal of invasive cardiology.

Case report describing balloon dilatation as a treatment for acute intraprosthetic regurgitation immediately following implantation of a SAPIEN‐3 transcatheter aortic valve

D. Chew, A. Sinhal, Nikhil Pal, 2021, Clinical Case Reports.

2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation.

Jeroen J. Bax, J. Mehilli, S. Windecker, 2015, Revista espanola de cardiologia.

Biomarker-based risk model to predict cardiovascular events in patients with acute coronary syndromes – Results from BIPass registry

D. Chew, Yuguo Chen, Jingjing Ma, 2022, The Lancet regional health. Western Pacific.

National Heart Foundation Response to Letter, “Ambiguous Cardiac Troponin Recommendations”

D. Chew, 2012 .

Socioeconomic Equity in the Receipt of In-Hospital Care and Outcomes in Australian Acute Coronary Syndrome Patients: The CONCORDANCE Registry.

M. Woodward, D. Chew, D. Brieger, 2017, Heart, lung & circulation.

Acute coronary syndrome care across Australia and New Zealand

I. Ranasinghe, F. Turnbull, D. Chew, 2013 .

The Last Mile: Improving Patient Outcomes within Modern Cardiovascular Medicine

D. Chew, Derek P. Chew, 2008 .

Extracorporeal Elimination of Large Concentrations of Tirofiban by Zero-Balanced Ultrafiltration During Cardiopulmonary Bypass: An In Vitro Investigation

A. Koster, D. Chew, F. Merkle, 2004, Anesthesia and analgesia.

High antithrombin III levels attenuate hemostatic activation and leukocyte activation during cardiopulmonary bypass.

R. Hetzer, W. Kuebler, A. Koster, 2003, The Journal of thoracic and cardiovascular surgery.

2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation.

Baris Gencer, Marco Valgimigli, Marco Roffi, 2015, Revista espanola de cardiologia.

Relative efficacy of bivalirudin versus heparin monotherapy in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: a network meta-analysis

D. Chew, U. Kaul, F. Schiele, 2013, Journal of blood medicine.

Thinking styles and doctors' knowledge and behaviours relating to acute coronary syndromes guidelines

P. Phillips, D. Chew, M. Bond, 2008, Implementation science : IS.

Coronary artery disease affecting the atrial branches is an independent determinant of atrial fibrillation after myocardial infarction.

W. Abhayaratna, P. Sanders, D. Leong, 2011, Heart rhythm.

The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis.

Prashanthan Sanders, Andrew D. McGavigan, Anand N. Ganesan, 2016, European heart journal.

Bivalirudin monitored with the ecarin clotting time for anticoagulation during cardiopulmonary bypass.

A. Koster, B. Spiess, D. Chew, 2003, Anesthesia and analgesia.

Quality of Life Changes in Acute Coronary Syndromes Patients: A Systematic Review and Meta-Analysis

H. Gesesew, B. Kaambwa, D. Chew, 2020, International journal of environmental research and public health.

Is Atrial Fibrillation a Stroke Risk Factor or Risk Marker? An Appraisal Using the Bradford Hill Framework for Causality.

D. Chew, J. Selvanayagam, A. McGavigan, 2019, Heart, lung & circulation.

A cohort study examination of established and emerging risk factors for atrial fibrillation: the Busselton Health Study

J. Eikelboom, J. Hung, M. Knuiman, 2014, European Journal of Epidemiology.

Use of clinical risk stratification in non-ST elevation acute coronary syndromes: an analysis from the CONCORDANCE registry

A. Yan, S. Goodman, J. Atherton, 2018, European heart journal. Quality of care & clinical outcomes.

Expertise and infrastructure capacity impacts acute coronary syndrome outcomes.

I. Ranasinghe, G. Gamble, D. Chew, 2017, Australian health review : a publication of the Australian Hospital Association.

National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016.

I. Scott, P. Aylward, D. Chew, 2016, Heart, lung & circulation.

Lost in Translation: Health Resource Variability in the Achievement of Optimal Performance and Clinical Outcome

P. Davidson, D. Chew, C. MacDougall, 2011, Circulation. Cardiovascular quality and outcomes.

Impact of acute and chronic risk factors on use of evidence-based treatments in patients in Australia with acute coronary syndromes

J. Amerena, D. Chew, D. Brieger, 2009, Heart.

National data elements for the clinical management of acute coronary syndromes

D. Chew, N. Sheerin, C. Aroney, 2005, The Medical journal of Australia.

A cluster randomized trial of objective risk assessment versus standard care for acute coronary syndromes: Rationale and design of the Australian GRACE Risk score Intervention Study (AGRIS).

G. Hillis, A. Yan, S. Goodman, 2015, American Heart Journal.

Perceived Risk of Ischemic and Bleeding Events in Acute Coronary Syndromes

D. Chew, P. Kerkar, W. Parsonage, 2013, Circulation. Cardiovascular quality and outcomes.

Evaluating recruitment strategies for AUSPICE, a large Australian community‐based randomised controlled trial

A. Thrift, A. Tonkin, W. Abhayaratna, 2019, The Medical journal of Australia.

Platelet inhibition with cangrelor in patients undergoing PCI.

Gregg W Stone, Deepak L. Bhatt, Deepak L Bhatt, 2009, The New England journal of medicine.

Cardiovascular disease and COVID-19: Australian and New Zealand consensus statement.

L. Thomas, G. Jennings, C. Chow, 2020, The Medical journal of Australia.

Impact of Surgical and Transcatheter Aortic Valve Replacement on Frailty Score.

D. Chew, J. Selvanayagam, C. D. De Pasquale, 2021, Heart, lung & circulation.

The interaction of vascular inflammation and chronic kidney disease for the prediction of long-term death after percutaneous coronary intervention.

Deepak L. Bhatt, S. Ellis, H. Gurm, 2005, American heart journal.

A critical appraisal of platelet glycoprotein IIb/IIIa inhibition.

D. Moliterno, D. Chew, Derek P. Chew, 2000, Journal of the American College of Cardiology.

Relation of Inflammation and Benefit of Statins After Percutaneous Coronary Interventions

Deepak L. Bhatt, E. Topol, S. Ellis, 2003, Circulation.

Performance of the European Society of Cardiology 0/1-Hour, 0/2-Hour, and 0/3-Hour Algorithms for Rapid Triage of Acute Myocardial Infarction

D. Atar, J. Pickering, S. Blankenberg, 2021, Annals of Internal Medicine.

Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial).

E. Topol, A. Lincoff, R. Harrington, 2004, The American journal of cardiology.

Increased Mortality With Oral Platelet Glycoprotein IIb/IIIa Antagonists: A Meta-Analysis of Phase III Multicenter Randomized Trials

Deepak L. Bhatt, E. Topol, D. Chew, 2001, Circulation.

Bivalirudin vs Heparin in Percutaneous Coronary Intervention: A Pooled Analysis

E. Topol, A. Lincoff, J. Bittl, 2005, Journal of cardiovascular pharmacology and therapeutics.

Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial.

E. Topol, A. Lincoff, J. Bittl, 2007, The American journal of cardiology.

Prognostic significance of creatine kinase-MB elevation after percutaneous coronary intervention in patients with chronic renal dysfunction.

Eric J Topol, E. Topol, A. Jeremias, 2002, American heart journal.

The management of acute coronary syndrome patients across New Zealand in 2012: results of a third comprehensive nationwide audit and observations of current interventional care.

I. Ranasinghe, H. White, G. Gamble, 2013, The New Zealand medical journal.

Incremental Prognostic Value of Elevated Baseline C-Reactive Protein Among Established Markers of Risk in Percutaneous Coronary Intervention

Deepak L. Bhatt, E. Topol, M. Lauer, 2001, Circulation.

The REPLACE 1 trial: a pilot study of bivalirudin versus heparin during percutaneous coronary intervention with stenting and GP IIb/IIIa blockade

E. Topol, A. Lincoff, R. Harrington, 2002 .

Reperfusion therapy in the acute management of ST‐segment‐elevation myocardial infarction in Australia: findings from the ACACIA registry

D. Chew, D. Brieger, J. Rankin, 2010, The Medical journal of Australia.

Safe and efficacious use of bivalirudin for percutaneous coronary intervention with adjunctive platelet glycoprotein IIb/IIIa receptor inhibition.

Deepak L. Bhatt, E. Topol, S. Ellis, 2003, The American journal of cardiology.

Clinical Risk Prediction Models for the Prognosis and Management of Acute Coronary Syndromes.

A. Yan, S. Goodman, K. Fox, 2021, European heart journal. Quality of care & clinical outcomes.

GRACE risk score: Sex-based validity of in-hospital mortality prediction in Canadian patients with acute coronary syndrome.

A. Yan, S. Goodman, R. Welsh, 2017, International journal of cardiology.

300 Circ Cardiovasc Qual Outcomes May 2013 Methods Study Design The Perceived Risk of Ischemic and Bleeding Events in Acute Coronary Syndrome Patients

D. Chew, P. Kerkar, W. Parsonage, 2013 .

Acute myocardial infarction

H. White, D. Chew, Harvey D White, 2008, The Lancet.

The role of antiplatelet therapy in the secondary prevention of coronary artery disease

P. Aylward, D. Chew, M. Behan, 2010, Current opinion in cardiology.

Impact of female sex on outcome after percutaneous coronary intervention.

Deepak L. Bhatt, E. Topol, S. Ellis, 2004, American heart journal.

Direct thrombin inhibition in percutaneous coronary intervention

H. White, D. Chew, S. Lehman, 2007 .

Outcomes in African Americans and whites after percutaneous coronary intervention.

Deepak L. Bhatt, E. Topol, S. Ellis, 2005, The American journal of medicine.

Renal failure after percutaneous coronary intervention is associated with high mortality

Deepak L. Bhatt, S. Ellis, H. Gurm, 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

The underutilisation of dual antiplatelet therapy in acute coronary syndrome.

A. Yan, S. Goodman, Anushka Patel, 2017, International journal of cardiology.

Association between admission white blood cell count and one-year mortality in patients with acute coronary syndromes.

Deepak L. Bhatt, E. Topol, L. Newby, 2003, The American journal of medicine.

Core Outcome Measures for Trials in People With Coronavirus Disease 2019: Respiratory Failure, Multiorgan Failure, Shortness of Breath, and Recovery

D. Needham, P. Horby, P. Póvoa, 2021, Critical care medicine.

Core Outcomes Set for Trials in People With Coronavirus Disease 2019

P. Horby, P. Póvoa, I. Douglas, 2020, Critical care medicine.

Validation of the "Doorbell Test": A Novel Functional Test of Frailty and Clinical Status After Acute Decompensated Heart Failure.

T. Marwick, D. Chew, C. D. De Pasquale, 2020, Heart, lung & circulation.

Guideline-indicated treatments and diagnostics, GRACE risk score, and survival for non-ST elevation myocardial infarction

M. Farkouh, H. Bueno, H. Hemingway, 2018, European heart journal.

Association of Clinical Factors and Therapeutic Strategies With Improvements in Survival Following Non-ST-Elevation Myocardial Infarction, 2003-2013.

H. Bueno, H. Hemingway, A. Yan, 2016, JAMA.

The value of "more" information: the emerging role of novel diagnostic investigations in cardiovascular medicine.

D. Chew, C. Astley, 2009, Heart, lung & circulation.

Cardiac MRI assessment of left and right ventricular parameters in healthy Australian normal volunteers.

D. Chew, S. Worthley, A. Carbone, 2008, Heart, lung & circulation.

Comparison of three risk stratification rules for predicting patients with acute coronary syndrome presenting to an Australian emergency department.

J. Greenslade, K. Chu, A. Brown, 2013, Heart, lung & circulation.

Troponin elevation pattern and subsequent cardiac and non-cardiac outcomes: Implementing the Fourth Universal Definition of Myocardial Infarction and high-sensitivity troponin at a population level

D. Chew, S. Lehman, J. French, 2021, PloS one.

Rational clinical evaluation of suspected acute coronary syndromes: The value of more information

D. Chew, W. Parsonage, L. Cullen, 2017, Emergency medicine Australasia : EMA.

High sensitivity-troponin elevation secondary to non-coronary diagnoses and death and recurrent myocardial infarction: An examination against criteria of causality

I. Scott, D. Chew, D. Brieger, 2015, European heart journal. Acute cardiovascular care.

Prognostic impact of moderate or severe mitral regurgitation (MR) irrespective of concomitant comorbidities: a retrospective matched cohort study

D. Chew, R. Prakash, A. Sinhal, 2014, BMJ Open.

Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial

C. Tsioufis, I. Meredith, V. Papademetriou, 2013, European heart journal.

2021 Asian Pacific Society of Cardiology Consensus Recommendations on the Use of P2Y12 Receptor Antagonists in the Asia-Pacific Region: Special Populations

W. Almahmeed, U. Baber, Q. Nguyen, 2021, European cardiology.

The Impact of Cardiac Rehabilitation and Secondary Prevention Programs on 12-Month Clinical Outcomes: A Linked Data Analysis.

R. Clark, R. Tavella, J. Beltrame, 2020, Heart, lung & circulation.

Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial.

E. Ohman, H. Barnhart, H. Thiele, 2011, JAMA.

Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients With Non–ST-Segment-Elevation Acute Coronary Syndromes

Deepak L. Bhatt, R. Califf, E. Topol, 2001, Circulation.

High-sensitivity troponin in chronic kidney disease: Considerations in myocardial infarction and beyond.

D. Chew, S. Lehman, A. Chuang, 2020, Reviews in cardiovascular medicine.

The impact of increased age on outcome from a strategy of early invasive management and revascularisation in patients with acute coronary syndromes: retrospective analysis study from the ACACIA registry

D. Chew, R. Prakash, C. Malkin, 2012, BMJ Open.

Peroxisome proliferator-activated receptor gamma agonists for the Prevention of Adverse events following percutaneous coronary Revascularization--results of the PPAR study.

Deepak L. Bhatt, S. Steinhubl, E. Topol, 2007, American heart journal.

Management of ST-elevation myocardial infarction

H. White, D. Chew, 2011 .

Multidisciplinary transcatheter aortic valve replacement heart team programme improves mortality in aortic stenosis

D. Chew, J. Selvanayagam, S. Lehman, 2019, Open Heart.

Advanced Echocardiographic Imaging for Prediction of SCD in Moderate and Severe LV Systolic Function.

C. Marx, D. Chew, R. Perry, 2020, JACC. Cardiovascular imaging.

Mobile health: an emerging technology with implications for global internal medicine

Anand Ganesan, R. Clark, D. Chew, 2017, Internal medicine journal.

The appropriateness of coronary investigation in myocardial injury and type 2 myocardial infarction (ACT‐2): A randomized trial design

H. White, I. Scott, M. Farkouh, 2019, American heart journal.

Coronary Artery Wall Thickness of the Left Anterior Descending Artery Using High Resolution Transthoracic Echocardiography – Normal Range of Values

P. Aylward, D. Chew, R. Perry, 2013, Echocardiography.

Perspectives of patients, family members, health professionals and the public on the impact of COVID-19 on mental health

P. Horby, P. Póvoa, I. Douglas, 2022, Journal of mental health.

Catheter-based renal denervation for resistant hypertension: Twenty-four month results of the EnligHTN I first-in-human study using a multi-electrode ablation system.

I. Kallikazaros, C. Tsioufis, I. Meredith, 2015, International journal of cardiology.

Variation in Clinical Practice: A Priority Setting Approach to the Staged Funding of Quality Improvement

J. Karnon, D. Chew, A. Partington, 2016, Applied Health Economics and Health Policy.

Applying a framework to assess the impact of cardiovascular outcomes improvement research

J. Beltrame, D. Chew, D. Brieger, 2021, Health Research Policy and Systems.

International Mobile-Health Intervention on Physical Activity, Sitting, and Weight: The Stepathlon Cardiovascular Health Study.

Andrew D. McGavigan, Anand N. Ganesan, Derek P. Chew, 2016, Journal of the American College of Cardiology.

A Randomized Trial of a 1-Hour Troponin T Protocol in Suspected Acute Coronary Syndromes: The Rapid Assessment of Possible ACS In the Emergency Department with High Sensitivity Troponin T (RAPID-TnT) Study.

J. Karnon, D. Chew, A. Nelson, 2019, Circulation.

Outcomes from the REACH Registry for Australian general practice patients with or at high risk of atherothrombosis

Deepak L. Bhatt, C. Reid, Z. Ademi, 2012, The Medical journal of Australia.

Cost effectiveness of a 1-hour high-sensitivity troponin-T protocol: An analysis of the RAPID-TnT trial

J. Karnon, D. Chew, T. Briffa, 2021, International Journal of Cardiology. Heart & Vasculature.

Cost effectiveness of high-sensitivity troponin compared to conventional troponin among patients presenting with undifferentiated chest pain: A trial based analysis.

J. Karnon, M. Arstall, J. Beltrame, 2017, International journal of cardiology.

TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol

G. Hillis, J. Atherton, S. Jan, 2018, BMJ Open.

Is There Inequity in Hospital Care Among Patients With Acute Coronary Syndrome Who Are Proficient and Not Proficient in English Language?: Analysis of the SNAPSHOT ACS Study

M. Woodward, R. Clark, G. Gamble, 2017, The Journal of cardiovascular nursing.

Is there inequity amongst patients with acute coronary syndrome who are proficient and not proficient in English language in terms of their in-hospital care: Analysis of the SNAPSHOT ACS Study

M. Woodward, Robyn, G. Gamble, 2016 .

Inequity in Hospital Care Among Patients With Acute Coronary Syndrome Who Are Proficient and Not Proficient in English Language?: Analysis of the SNAPSHOT

M. Woodward, Robyn, G. Gamble, 2016 .

Prescription of secondary prevention medications, lifestyle advice, and referral to rehabilitation among acute coronary syndrome inpatients: results from a large prospective audit in Australia and New Zealand

I. Ranasinghe, F. Turnbull, C. Chow, 2014, Heart.

SNAPSHOT ACS Cohort Follow-Up – What Happens to Australian Patients in the 3 Years after Hospital Discharge: A National Data Linkage Study

D. Chew, D. Brieger, T. Briffa, 2019, Heart, Lung and Circulation.

Prognostic value of adenosine stress perfusion cardiac MRI with late gadolinium enhancement in an intermediate cardiovascular risk population.

D. Chew, A. Nelson, M. Worthley, 2013, International journal of cardiology.

Type-II myocardial infarction and chronic myocardial injury rates, invasive management, and 4-year mortality among consecutive patients undergoing high-sensitivity troponin T testing in the emergency department.

D. Chew, S. Frost, J. French, 2019, European heart journal. Quality of care & clinical outcomes.

International Survey to Establish Prioritized Outcomes for Trials in People With Coronavirus Disease 2019

P. Horby, P. Póvoa, I. Douglas, 2020, Critical care medicine.

Predicting Australian Adults at High Risk of Cardiovascular Disease Mortality Using Standard Risk Factors and Machine Learning

J. Shaw, T. Gill, A. Maeder, 2021, International journal of environmental research and public health.

Clopidogrel pretreatment prior to percutaneous coronary intervention attenuates periprocedural rise of C-reactive protein

Deepak L. Bhatt, E. Topol, S. Ellis, 2003 .

Contrasting the potential benefits of early invasive coronary angiography in acute and chronic myocardial injury patterns

D. Chew, C. D. De Pasquale, S. Lehman, 2023, PloS one.

Impact of increased augmentation index and valvuloarterial impedance on symptom recovery after aortic valve replacement for severe aortic stenosis

D. Chew, J. Selvanayagam, C. D. De Pasquale, 2021, International journal of cardiology. Heart & vasculature.

Prognostic implications of high sensitivity Troponin T levels among patients attending emergency departments and evaluated for an acute coronary syndrome.

D. Chew, S. Frost, J. French, 2021, American Journal of Medicine.

Objective Risk Assessment vs Standard Care for Acute Coronary Syndromes: A Randomized Clinical Trial.

G. Hillis, A. Yan, S. Goodman, 2020, JAMA cardiology.

Clinical risk scores in ACS management: Current and future directions

D. Chew, Leong Lee, 2012 .

Chest Pain Management Using Prehospital Point-of-Care Troponin and Paramedic Risk Assessment.

C. Mihalopoulos, D. Stub, J. Ball, 2023, JAMA internal medicine.

Implementation and prospective evaluation of the Country Heart Attack Prevention model of care to improve attendance and completion of cardiac rehabilitation for patients with cardiovascular diseases living in rural Australia: a study protocol

C. Maher, R. Tavella, J. Beltrame, 2022, BMJ Open.

Invasive management of acute coronary syndrome: Interaction with competing risks.

D. Chew, C. D. De Pasquale, A. Sinhal, 2018, International journal of cardiology.

Present and potential future paradigms for the treatment of ST-segment elevation acute myocardial infarction.

H. Herrmann, D. Moliterno, D. Chew, 2002, The Journal of invasive cardiology.

The Heart Health Study - increasing cardiovascular risk assessment in family practice for first degree relatives of patients with premature ischaemic heart disease: a randomised controlled trial

N. Stocks, G. Wittert, D. Chew, 2015, BMC Family Practice.

Assessment of early diastolic left ventricular function by two-dimensional echocardiographic speckle tracking.

D. Chew, R. Perry, C. D. De Pasquale, 2008, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

Classification performance of clinical risk scoring in suspected acute coronary syndrome beyond a rule-out troponin profile.

D. Chew, A. Nelson, T. Briffa, 2021, European heart journal. Acute cardiovascular care.

[2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation].

Jeroen J. Bax, J. Mehilli, S. Windecker, 2015, Kardiologia polska.

Coronary artery bypass surgery in patients with acute coronary syndromes is difficult to predict.

R. Califf, H. White, K. Mahaffey, 2008, American heart journal.

Third Generation P2Y12 Inhibition for East Asian ACS Patients

D. Chew, Y. S. Keh, Jack Wei Chieh Tan, 2022, JACC. Asia.

Nationally linked data to improve health services and policy

D. Chew, T. Briffa, Louisa R Jorm, 2019, The Medical journal of Australia.

Invasive management and late clinical outcomes in contemporary Australian management of acute coronary syndromes: observations from the ACACIA registry

J. Amerena, D. Chew, D. Brieger, 2008, The Medical journal of Australia.